Abstract
Ventricular fibrillation developed in a 19 year old woman taking the antihistamine astemizole. She was successfully resuscitated. QTc prolongation was found and persisted despite withdrawal of the drug. Aggravation of congenital long QTc syndrome by astemizole is postulated. More caution should be exercised with the use of this drug.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Craft T. M., Vanden Bussche G., De Cree J., Griffiths J. V. ECG studies with astemizole. Hum Toxicol. 1987 Nov;6(6):527–528. doi: 10.1177/096032718700600614. [DOI] [PubMed] [Google Scholar]
- Levi R., Kuye J. O. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-receptor antagonists. Eur J Pharmacol. 1974 Aug;27(3):330–338. doi: 10.1016/0014-2999(74)90008-9. [DOI] [PubMed] [Google Scholar]
- Moss A. J., Schwartz P. J., Crampton R. S., Locati E., Carleen E. The long QT syndrome: a prospective international study. Circulation. 1985 Jan;71(1):17–21. doi: 10.1161/01.cir.71.1.17. [DOI] [PubMed] [Google Scholar]
- Moss A. J., Schwartz P. J., Crampton R. S., Tzivoni D., Locati E. H., MacCluer J., Hall W. J., Weitkamp L., Vincent G. M., Garson A., Jr The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991 Sep;84(3):1136–1144. doi: 10.1161/01.cir.84.3.1136. [DOI] [PubMed] [Google Scholar]
- Pohjola-Sintonen S., Viitasalo M., Toivonene L., Neuvonen P. Torsades de pointes after terfenadine-itraconazole interaction. BMJ. 1993 Jan 16;306(6871):186–186. doi: 10.1136/bmj.306.6871.186. [DOI] [PMC free article] [PubMed] [Google Scholar]